|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Fair Value | ||||||||||||
| Non-controlled/non-affiliated investments | ||||||||||||
| Non-controlled/affiliated investments | ||||||||||||
| Total fair Value | ||||||||||||
| Cash and cash equivalents | ||||||||||||
| Restricted cash | ||||||||||||
| Derivatives, at fair value | ||||||||||||
| Receivables for investments sold | ||||||||||||
| Interest and other receivables | ||||||||||||
| Deferred debt issuance costs | ||||||||||||
| Prepaid expenses and other assets | ||||||||||||
| Total assets | ||||||||||||
| Liabilities | ||||||||||||
| Debt | ||||||||||||
| Incentive fees payable | ||||||||||||
| Interest and other debt related payables | ||||||||||||
| Distributions payable | ||||||||||||
| Payable for investments purchased | ||||||||||||
| Payable to broker | ||||||||||||
| Management fees payable | ||||||||||||
| Accrued expenses and other liabilities | ||||||||||||
| Total liabilities | ||||||||||||
| Net Assets | ||||||||||||
| Composition of net assets applicable to common shareholders | ||||||||||||
| Common stock, $0.001 par value (1,000,000,000 shares authorized, 17,099,468 and 16,793,031 shares issued and outstanding, respectively) | ||||||||||||
| Paid-in capital in excess of par | ||||||||||||
| Distributable earnings (deficit) | ||||||||||||
| Total net assets | ||||||||||||
| Total liabilities and net assets | ||||||||||||
| Shares outstanding | ||||||||||||
| Net asset value per share |
Loading...
